| Dr Jan Veinot, PHD | |
|
41 Bayview St, Yarmouth, ME 04096-6900 | |
| (207) 712-2597 | |
| Not Available |
| Full Name | Dr Jan Veinot |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 41 Bayview St, Yarmouth, Maine |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346644010 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | XL4393 (Maine) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jan Veinot, PHD 41 Bayview St, Yarmouth, ME 04096-6900 Ph: (207) 712-2597 | Dr Jan Veinot, PHD 41 Bayview St, Yarmouth, ME 04096-6900 Ph: (207) 712-2597 |
News Archive
Researchers at the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, Missouri, a national leader in the early adoption and use of advanced treatments for cancer patients, will soon become the first in the world to test an innovative radiotherapy system from ViewRay, Inc. The ViewRay system is designed to improve the accuracy of cancer treatments through a combination of medical imaging and radiotherapy delivery.
A research team led by the University of Colorado at Boulder has discovered a previously unknown cellular "switch" that may provide researchers with a new means of triggering programmed cell death, findings with implications for treating cancer.
For the third time in one year, the German Institute for Quality and Efficiency in Health Care (IQWiG) dealt with the drug aflibercept. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG), the Institute now examined whether aflibercept (trade name: Eylea) offers an added benefit over the appropriate comparator therapy in visual impairment due to macular oedema following occlusion of the central retinal vein.
Researchers from the National Institute of Allergy and Infectious Diseases (NIAID) provide the first proof of concept data showing that a monoclonal antibody can neutralize human norovirus. This research, which could one day lead to effective therapies against the virus, was published online ahead of print in the Journal of Virology.
› Verified 8 days ago
Deborah Bry, MA, CHT Counselor Medicare: Not Enrolled in Medicare Practice Location: 265 Cousins St, Yarmouth, ME 04096 Phone: 415-671-9716 | |
Dr. Dane Frost, LCPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 40 Forest Falls Dr Ste 301, Yarmouth, ME 04096 Phone: 207-604-0987 Fax: 301-329-2315 | |
Mrs. Beth Ann Andrews, LCSW, LADC, CCS Counselor Medicare: Not Enrolled in Medicare Practice Location: 261 Main St, Yarmouth, ME 04096 Phone: 207-650-2011 | |
Danielle Rideout, LADC, CCS Counselor Medicare: Not Enrolled in Medicare Practice Location: 24 Bowdoin St, Yarmouth, ME 04096 Phone: 207-329-2267 | |
Cathleen M. Dimarzio, LCPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 325 Main St Ste 6, Yarmouth, ME 04096 Phone: 207-846-1008 | |
Ms. Carolee Lindsey, LCSW, LADC Counselor Medicare: Accepting Medicare Assignments Practice Location: 45 Forest Falls Dr, Ste B2, Yarmouth, ME 04096 Phone: 207-329-7611 | |
Sarah B Mckinnon, Counselor Medicare: Not Enrolled in Medicare Practice Location: 87 Main St, Yarmouth, ME 04096 Phone: 207-650-9292 |